Urolithiasis With Topiramate in Nonambulatory Children and Young Adults

Pediatric Neurology

Volumn 40, Issue 4, 2009, Pages 289-294

  Goyal, Monisha ^a   Grossberg, Richard I ^b   O'Riordan, Mary Ann ^a   Davis, Ira D ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b Hattie Larlham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CITRIC ACID; TOPIRAMATE;

ADOLESCENT; ADULT; AMBULATORY CARE; ARTICLE; CHILD; CONTROL GROUP; CONTROLLED STUDY; DEVELOPMENTAL DISORDER; DRUG WITHDRAWAL; FEMALE; HEALTH CARE FACILITY; HUMAN; LITHOTRIPSY; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MENTAL DEFICIENCY; MONOTHERAPY; NEPHROLITHIASIS; OSTEOMALACIA; PERCUTANEOUS NEPHROSTOMY; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROPERITONEAL HEMORRHAGE; RETROSPECTIVE STUDY; TREATMENT DURATION; UROLITHIASIS; UROSEPSIS; VITAMIN SUPPLEMENTATION;

ADOLESCENT; ADULT; ANTICONVULSANTS; CHILD; CHILD, PRESCHOOL; CITRATES; DEVELOPMENTAL DISABILITIES; FEMALE; FRUCTOSE; HUMANS; MALE; MENTAL RETARDATION; MIDDLE AGED; RETROSPECTIVE STUDIES; UROLITHIASIS; YOUNG ADULT;

EID: 62149095077     PISSN: 08878994     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pediatrneurol.2008.11.004     Document Type: Article

References (32)

1. Kroovand R. Urolithiasis. Urol Clin North Am 24 (1997) 173-184
2. Manthey D.E., and Tiechman J. Genitourinary emergencies: Nephrolithiasis. Emerg Med Clin North Am 19 (2001) 633-654
3. Furth S.L., Casey J.C., Pyzik P.L., et al. Risk factors for urolithiasis in children on the ketogenic diet. Pediatr Nephrol 15 (2000) 125-128
4. Choi H., Snyder H.M.I., and Duckett J.W. Urolithiasis in childhood: Current management. J Pediatr Surg 72 (1987) 158
5. Minevich E. Pediatric urolithiasis. Pediatr Clin North Am 48 (2001) 1571-1585
6. Cameron M., Sakhaee K., and Moe O. Nephrolithiasis in children. Pediatr Nephrol 20 (2005) 1587-1592
7. Wassersteub A., Rak I., and Reife R. Nephrolithiasis during treatment with topiramate. Epilepsia 36 Suppl. 3 (1995) 153
8. Kumar N., Khwaja G.A., Gupta M., et al. Antiepileptic drug induced osteomalacic myopathy with hyperparathyroidism and nephrolithiasis. J Assoc Physicians India 41 (1993) 748-749
9. Daudon M., and Jungers P. Drug-induced renal calculi. Drugs 64 (2004) 245-275
10. Tohshin G. Effect of antiepileptic drug polytherapy on crystalluria. Pediatr Neurol 32 (2005) 113-115
11. Bartosh S.M. Medical management of pediatric stone disease. Urol Clin North Am 31 (2004) 575-587
12. Stapleton F.B., Noe H.N., Roy III S., et al. Hypercalciuria in children with urolithiasis. Am J Dis Child 136 (1982) 675-678
13. Stapleton F.B., Noe H.N., Jerkins G.R., et al. Urinary excretion of calcium following an oral calcium-loading test in healthy children. Pediatrics 69 (1982) 594-597
14. Santos-Victoriano M., Brouhard B.H., and Cunningham R.J. Renal stone disease in children. Clin Pediatr (Phila) 37 (1998) 583-600
15. Matos V. Urinary oxalate and urate to creatinine rations in a healthy pediatric population. Am J Kidney Dis 34 (1999) e1
16. Polinsky M.S., Kaiser K.A., Baluarte H.J., et al. Renal stones and hypercalciuria. Adv Pediatr 40 (1993) 353-384
17. Hoppe B., and Langman C.B. Hypocitraturia in patients with urolithiasis. Arch Dis Child 76 (1997) 174-175
18. Vega D., Maalouf N.M., and Sakhaee K. Increased propensity for calcium phosphate kidney stones with topiramate use. Expert Opin Drug Saf 6 (2007) 547-557
19. Müller C.E., Bianchetti M., and Kaiser G. Immobilization, a risk factor for urinary tract stones in children: A case report. Eur J Pediatr Surg 4 (1994) 201-204
20. Takeoka M., Holmes G.L., Thiele E., et al. Topiramate and metabolic acidosis in pediatric epilepsy. Epilepsia 42 (2001) 387-392
21. Wiederkehr M., and Krapf R. Metabolic and endocrine effects of metabolic acidosis in humans. Swiss Med Wkly 131 (2001) 127-132
22. Pak C., Poindexter J., Adams-Huet B., et al. Predictive value of kidney stone composition in the detection of metabolic abnormalities. Am J Med 115 (2003) 26-32
23. Lamb E. Topiramate increases biochemical risk of nephrolithiasis. Ann Clin Biochem 41 (2004) 166-169
24. Welch B.J., Graybeal D., Moe O.W., et al. Biochemical and stone-risk profiles with topiramate treatment. Am J Kidney Dis 48 (2006) 555-563
25. Gokce C., Gokce O., Baydine C., et al. Use of random urine samples to estimate total urinary calcium and phosphate excretion. Arch Intern Med 151 (1991) 1587-1588
26. Kuo R., Moran M., Kim D., et al. Topiramate-induced nephrolithiasis. J Endourol 16 (2002) 229-231
27. Bootsma H.P., Coolen F., Aldencamp A.P., et al. Topiramate in clinical practice: Long term experience in patients with refractory epilepsy referred to a tertiary epilepsy center. Epilepsy Behav 5 (2004) 380-387
28. Coppola G., Caliendo G., Veggiotti P., et al. Topiramate as add on drug in children, adolescents, and young adults with Lennox-Gastaut syndrome: An Italian multicentric study. Epilepsy Res 51 (2002) 147-153
29. Sauerwein D. Urinary tract infection in patients with neurogenic bladder dysfunction. Int J Antimicrob Agents 19 (2002) 592-597
30. Matlaga B., Kim S., Watkins S., et al. Changing composition of renal calculi in patients with neurogenic bladder. J Urol 175 (2006) 1716-1719
31. Wilson D. Clinical and laboratory evaluation of renal stone patients. Endocrinol Metab Clin North Am 19 (1990) 773-803
32. Pearle M.S. Prevention of nephrolithiasis. Curr Opin Nephrol Hypertens 10 (2001) 203-209